SFI
LMNL

Susquehanna Fundamental Investments’s Liminal BioSciences Inc. Common Shares LMNL Stock Holding History

Susquehanna Fundamental Investments’s Portfolio LMNL Stock Details LMNL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,177
Closed -$27K – 1835
2021
Q3 		$27K Sell
1,177
-983
-46% -$28.3K ﹤0.01% 1673
2021
Q2 		$84K Sell
2,160
-1,180
-35% -$51.4K ﹤0.01% 1584
2021
Q1 		$138K Sell
3,340
-3,502
-51% -$170K ﹤0.01% 1438
2020
Q4 		$287K Buy
+6,842
New +$374K 0.01% 1273

Other funds holding LMNL

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
ECM
Estabrook Capital Management New York $685M AUM 26.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Susquehanna Fundamental Investments's LMNL Position: Q4 2021 in Review

Susquehanna Fundamental Investments sold out of Liminal BioSciences Inc. Common Shares (LMNL) in Q4 2021, closing a stake of 1,177 shares — an estimated $27K sold.

Susquehanna Fundamental Investments first reported a position in LMNL in Q4 2020 and held it in 4 quarters. The position peaked at $287K in Q4 2020. 18 funds tracked by Wall St. Rank hold LMNL as of Q4 2021.

  • Susquehanna Fundamental Investments reported no remaining Liminal BioSciences Inc. Common Shares position as of Q4 2021 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 1,177 Liminal BioSciences Inc. Common Shares shares in Q4 2021, an estimated $27K.
  • Susquehanna Fundamental Investments first reported a position in Liminal BioSciences Inc. Common Shares in Q4 2020 and held it in 4 quarters.
  • Susquehanna Fundamental Investments's Liminal BioSciences Inc. Common Shares position peaked at $287K in Q4 2020.
  • 18 funds tracked by Wall St. Rank held Liminal BioSciences Inc. Common Shares as of Q4 2021.

Based on Susquehanna Fundamental Investments's 13F filing for Q4 2021, filed 14 Feb 2022.